Related Experiment Video
Updated: Aug 2, 2026

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
Published on: April 20, 2018
Alveolar macrophage populations are distorted in immunocompromised patients with pneumonitis
D H Bray1, S B Squire, E Bagdades
1Dept of Clinical Immunology, Royal Free Hospital and School of Medicine, London, UK.
Abstract:
Alveolar macrophages (AM) were obtained by bronchoalveolar lavage (BAL) from patients presenting with pneumonitis: 30 human immunodeficiency virus (HIV)-infected individuals and 12 transplant recipients. Nine normal volunteers acted as controls. The cells were washed and cytospins prepared. Monoclonal antibodies (MoAbs) and immunoperoxidase methods were used to analyse the expression of HLA-DR molecules as well as phenotypic macrophage markers. P values apply to the differences between medians using the Mann-Whitney test. Median percentages of macrophages, lymphocytes and neutrophils were similar in all three groups. No differences were found in the median percentages of macrophages expressing the monocyte phenotype (MoAb UCHM1, CD14). However, in HIV-infected patients and transplant recipients a median of only 45% of macrophages expressed the pan-macrophage phenotype identified by MoAb EBM11 (CD68) in contrast with 98% in the normal volunteers. The AM population expressing the dendritic cell marker (MoAb RFD1) was also markedly reduced in both groups of immunocompromised patients (2 vs 28% in normal volunteers). Transplant recipients had significantly more phagocytic cells identified by MoAb RFD7 than the HIV-infected patients (25 vs 2%), but the numbers were still low when compared with the volunteers (48%). HLA-DR expression on BAL cells was reduced by 90% in both immunocompromised groups. For the transplant recipients, severity of pneumonitis was correlated with expression of dendritic cell marker RFD1, (Spearman's rank correlation r = 0.538, p less than 0.05) and pan-macrophage marker EBM11 (r = 0.581, p less than 0.05), while no such correlation was found in HIV-infected patients. These results suggest that a defective macrophage population is probably a serious factor contributing to immunosuppression.
Insights
Alveolar macrophages in HIV and transplant patients show reduced expression of key markers, indicating a defective macrophage population contributing to immunosuppression. This study highlights immune cell dysfunction in immunocompromised individuals.
Area of Science:
- Immunology
- Cell Biology
- Infectious Diseases
Background:
- Alveolar macrophages (AM) play a crucial role in lung immunity.
- Immunocompromised states, such as human immunodeficiency virus (HIV) infection and organ transplantation, are associated with increased susceptibility to infections, often due to impaired immune responses.
Purpose of the Study:
- To investigate the phenotypic characteristics and functional status of alveolar macrophages in patients with pneumonitis related to HIV infection and organ transplantation.
- To compare AM populations in immunocompromised patients with those in healthy volunteers.
Main Methods:
- Bronchoalveolar lavage (BAL) was performed to obtain alveolar macrophages from HIV-infected patients, transplant recipients, and normal volunteers.
- Immunoperoxidase staining with monoclonal antibodies (MoAbs) was used to analyze the expression of macrophage (CD68, CD14), dendritic cell (RFD1), phagocytic (RFD7), and HLA-DR markers.
Main Results:
- HIV-infected patients and transplant recipients showed significantly reduced expression of the pan-macrophage marker (CD68) and the dendritic cell marker (RFD1) compared to controls.
- Phagocytic cell (RFD7) numbers were higher in transplant recipients than in HIV patients but lower than in controls.
- HLA-DR expression on BAL cells was markedly reduced (by 90%) in both immunocompromised groups.
Conclusions:
- Alveolar macrophages in HIV-infected and transplant recipients exhibit significant phenotypic defects, characterized by reduced expression of key surface markers.
- These macrophage dysfunctions likely contribute to the impaired immune response and increased susceptibility to infections observed in these immunocompromised patient groups.
- The findings suggest that targeting macrophage function could be a potential therapeutic strategy in managing pneumonitis in immunocompromised individuals.
More Related Videos
Related Concept Videos
Alveoli and Alveolar Ducts
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease II: Emphysema
Pneumonia I: Introduction

